Hey there! Welcome!
Get updated on
Top Picks

calendar
1 Mar, 24
dot
link
Source

calendar
26 Mar, 24
This Indian study demonstrated telmisartan to be efficacious and tolerable for BP control in Indian hypertension patients when used as monotherapy or in combination therapy. The benefits of telmisartan were independent of age, duration, and stages of hypertension.

calendar
16 Apr, 24
dot
link
BMC Oral Health.
In a recent investigation among adults in the United States, researchers observed a positive correlation between mean platelet volume (MPV) & periodontal disease. Individuals with moderate to severe periodontitis exhibited higher MPV levels (OR = 1.090). Specifically, those in the upper tertile of MPV demonstrated a 21.6% increased likelihood of developing periodontitis vs. those in the lowest tertile (OR = 1.216).

calendar
16 Apr, 24
dot
link
JAMA Netw Open.
Over a 17-year study period, researchers observed that women with untreated or newly diagnosed hypertension faced an elevated risk of developing fibroids (Hazard ratios, 1.19 & 1.45 respectively). Conversely, those receiving antihypertensive treatment showed a reduced risk (HR, 0.63), suggesting that managing blood pressure could potentially serve as a preventive measure against fibroids.
Pulse IconPulse CheckCounter Icon0

How frequently do you encounter a history of hypertension in women who present with fibroids?


calendar
17 Apr, 24
dot
link
Cureus
  • Common gram-positive bacteria: S. aureus, Staphylococci, and Enterococcus spp. Highly resistant to fluoroquinolones, macrolides, and penicillin
  • Common gram-negative bacteria: K. pneumoniae, E. coli, and Acinetobacter spp. More antibiotic-resistant infections compared to gram-positive bacteria. Beta-lactams, fluoroquinolones, macrolides, and cephalosporins showing varied percentages of resistance

calendar
17 Apr, 24
dot
link
Diabetes Obes Metab.
  • The incidence of CV events was compared in new GLP-1RA & SGLT2i users with/without CKD [CKD stages: G1 or G2 (eGFR ≥60 ml/min/1.73 m2) & A2 (UACR 30 to <300 mg/g) or A3 (UACR ≥300 mg/g), stage G3a (eGFR 45 to <60 ml/min/1.73 m2) & G3b (eGFR 30 to <45 ml/min/1.73 m2)
  • SGLT-2 inhibitors were linked to 14% lower risk of non-fatal MI/ stroke vs. GLP-1 RAs
  • Benefits were seen across all CKD stages (G1-G3b) studied

home
home
home